Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method

.blurhash-client-img { display: none !important; }

Open Access

|Dec 2020

Authors

School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China

Department of Pharmacy, The First Affiliated Hospital, Xi′an Jiaotong University, China

Department of Pharmacology, School of Basic Medical Science, Xi′an Jiaotong University, Xi′an, China

Department of Pharmacy, The First Affiliated Hospital, Xi′an Jiaotong University, China

Department of Pharmacology, School of Basic Medical Science, Xi′an Jiaotong University, Xi′an, China

Department of Pharmacology, School of Basic Medical Science, Xi′an Jiaotong University, Xi′an, China

DOI: https://doi.org/10.2478/acph-2021-0024 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Language: English

Page range: 415 - 428

Accepted on: Aug 4, 2020

Published on: Dec 31, 2020

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2020 Sai-Jie Zuo, Xiao-Liang Cheng, Dong-Zheng Liu, Wei-Yi Feng, Yong-Xiao Cao, San-Qi Zhang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.